These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2499347)

  • 21. The role of proteases and exotoxin A in the pathogenicity of Pseudomonas aeruginosa infections.
    Wretlind B; Pavlovskis OR
    Scand J Infect Dis Suppl; 1981; 29():13-9. PubMed ID: 6797058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzyme-linked immunosorbent assay for Pseudomonas aeruginosa exotoxin A.
    Schultz WW; Phipps TJ; Pollack M
    J Clin Microbiol; 1979 Jun; 9(6):705-8. PubMed ID: 115899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Protective polysaccharide-protein artificial antigens from O-specific polysaccharides of Pseudomonas aeruginosa and its exotoxin A].
    Dmitriev BA; Kul'shin VA; Antsiferova NG; Vovk VA; Moroz AF
    Dokl Akad Nauk SSSR; 1988; 298(5):1277-80. PubMed ID: 2454182
    [No Abstract]   [Full Text] [Related]  

  • 24. Toxoids of Pseudomonas aeruginosa exotoxin-A: photoaffinity inactivation of purified toxin and purified toxin derivatives.
    Callahan LT; Martinez D; Marburg S; Tolman RL; Galloway DR
    Infect Immun; 1984 Mar; 43(3):1019-26. PubMed ID: 6321348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of extracellular virulence factors by Pseudomonas aeruginosa isolates obtained from tracheal, urinary tract, and wound infections.
    Hamood AN; Griswold JA; Duhan CM
    J Surg Res; 1996 Mar; 61(2):425-32. PubMed ID: 8656619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudomonas aeruginosa exoproducts as pulmonary virulence factors.
    Cash HA; Straus DC; Bass JA
    Can J Microbiol; 1983 Apr; 29(4):448-56. PubMed ID: 6406026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection.
    Blackwood LL; Stone RM; Iglewski BH; Pennington JE
    Infect Immun; 1983 Jan; 39(1):198-201. PubMed ID: 6401692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of recombinant atoxic form of exotoxin A from Pseudomonas aeruginosa.
    Kaloshin AA; Isakov MA; Mikhailova NA; Vertiev JV
    Bull Exp Biol Med; 2013 Jan; 154(3):346-50. PubMed ID: 23484197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of Pseudomonas aeruginosa exotoxin by affinity chromatography.
    Taylor NS; Pollack M
    Infect Immun; 1978 Jan; 19(1):66-70. PubMed ID: 415008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Extracellular enzymes of Pseudomonas aeruginosa as virulence factors].
    Jaeger KE
    Immun Infekt; 1994 Oct; 22(5):177-80. PubMed ID: 7982713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine potential of Pseudomonas aeruginosa O-polysaccharide-toxin A conjugates.
    Cryz SJ; Lang AB; Sadoff JC; Germanier R; Fürer E
    Infect Immun; 1987 Jul; 55(7):1547-51. PubMed ID: 3110065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The furin inhibitor hexa-D-arginine blocks the activation of Pseudomonas aeruginosa exotoxin A in vivo.
    Sarac MS; Cameron A; Lindberg I
    Infect Immun; 2002 Dec; 70(12):7136-9. PubMed ID: 12438396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significance of Pseudomonas aeruginosa virulence factors for acute and chronic Pseudomonas aeruginosa infections].
    Döring G
    Infection; 1987; 15 Suppl 2():S38-41. PubMed ID: 3112018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responses of adult volunteers to a Pseudomonas aeruginosa exotoxoid-A vaccine.
    Lydick E; Mclean AA; Woodhour AF; Callahan LT
    J Infect Dis; 1985 Feb; 151(2):375. PubMed ID: 3918128
    [No Abstract]   [Full Text] [Related]  

  • 35. Temperature-dependent inactivating factor of Pseudomonas aeruginosa exotoxin A.
    Vasil ML; Liu PV; Iglewski BH
    Infect Immun; 1976 May; 13(5):1467-72. PubMed ID: 178606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pseudomonas aeruginosa toxoid].
    Ianishevskaia MN
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):27-32. PubMed ID: 3922181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective activity of anti-exotoxin A monoclonal antibody against mice infected with toxin-producing Pseudomonas aeruginosa.
    Kohzuki T; Eguchi Y; Kato M; Irie K; Ohtsuka H; Higuchi A; Noguchi H
    J Infect Dis; 1993 Jan; 167(1):119-25. PubMed ID: 8418158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical and genetic aspects of Pseudomonas aeruginosa virulence.
    Lory S; Tai PC
    Curr Top Microbiol Immunol; 1985; 118():53-69. PubMed ID: 2414071
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients.
    Jagger KS; Robinson DL; Franz MN; Warren RL
    J Clin Microbiol; 1982 Jun; 15(6):1054-8. PubMed ID: 6809785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of antibody response to Pseudomonas aeruginosa in patients with wound infections.
    Trafny EA; Grzybowski J; Patzer J; Popiel D; Wrembel-Wargocka J; Dzierzanowska D; Zawistowska-Marciniak I; Kobus K
    Microbiol Immunol; 1991; 35(6):435-42. PubMed ID: 1921760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.